Related Experiment Video
Updated: Jun 20, 2026
08:41
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Angiogenesis and liver fibrogenesis
Lorenzo Valfrè di Bonzo1, Erica Novo, Stefania Cannito
1Department of Experimental Medicine and Oncology and Interuniversitary Centre of Hepatic Pathophysiology, University of Torino, Italy.
Histology and Histopathology
|August 19, 2009
Summary
Hepatic angiogenesis, the growth of new liver blood vessels, is linked to liver fibrosis progression. Hypoxia and activated hepatic stellate cells (HSCs) play key roles in this process.
Area of Science:
- Hepatology
- Vascular Biology
- Cell Biology
Background:
- Angiogenesis is a physiological process involving new blood vessel formation.
- Hepatic angiogenesis occurs in various liver conditions, including inflammation, fibrosis, and ischemia.
- Existing evidence links hepatic angiogenesis to the progression of chronic liver diseases.
Purpose of the Study:
- To review in vivo and in vitro evidence on the role of angiogenesis in chronic liver diseases.
- To outline the cellular and molecular mechanisms involved in hepatic angiogenesis.
- To emphasize the roles of hypoxia and hepatic stellate cells (HSCs) in liver fibrogenesis.
Main Methods:
- Review of current experimental (in vivo and in vitro) studies.
- Analysis of literature evidence on hepatic angiogenesis and liver disease.
- Focus on cellular and molecular mechanisms, particularly hypoxia and HSCs.
Main Results:
- Hepatic angiogenesis is associated with inflammatory, fibrotic, and ischemic liver conditions.
- Literature strongly suggests hepatic angiogenesis favors fibrogenic progression in chronic liver diseases.
- Hypoxic conditions and activated HSCs are crucial players in this pathogenetic role.
Conclusions:
- Angiogenesis plays a significant pathogenetic role in chronic liver diseases.
- Hypoxia and activated hepatic stellate cells are critical mediators linking angiogenesis to liver fibrosis.
- Understanding these mechanisms may offer therapeutic targets for liver disease.
More Related Videos
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
06:463D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis
Published on: February 25, 2022
Related Concept Videos
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:24Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:11Healing I: Introduction
Healing is the physiological process by which the body restores the integrity and function of damaged tissues following injury. It involves a coordinated interplay of cellular proliferation, extracellular matrix remodeling, and growth factor signaling. The extent and nature of the tissue damage determine whether healing occurs by resolution, regeneration, or replacement.ResolutionResolution represents the most complete form of healing, occurring when the injury is minimal and tissue...